Over- and under-prophylaxis for chemotherapy-induced (febrile) neutropenia relative to evidence-based guidelines is associated with differences in outcomes: findings from the MONITOR-GCSF study

PURPOSE: In the MONITOR-GCSF study of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim, 56.6% of patients were prophylacted according to amended EORTC guidelines, but 17.4% were prophylacted below and 26.0% above guideline recommendations. METHODS: MONITOR-GCSF is a prospective,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bokemeyer, Carsten, Gascón, Pere, Aapro, Matti, Ludwig, Heinz, Boccadoro, Mario, Denhaerynck, Kris, Gorray, Michael, Krendyukov, Andriy, Abraham, Ivo, MacDonald, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403842/
https://www.ncbi.nlm.nih.gov/pubmed/28111718
http://dx.doi.org/10.1007/s00520-017-3572-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403842/
https://www.ncbi.nlm.nih.gov/pubmed/28111718
http://dx.doi.org/10.1007/s00520-017-3572-4

Ejemplares similares